Related Experiment Videos
Abnormal thallium 201 scintigraphy during low-dose vasopressin infusions
Chest
|December 1, 1986
Summary
Vasopressin infusions can reduce blood flow to the heart, causing abnormal Thallium 201 (201Tl) myocardial scans. These perfusion defects typically resolve after stopping the vasopressin treatment.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Vasopressin is used to treat upper gastrointestinal bleeding.
- Cardiovascular side effects are associated with vasopressin use.
Purpose of the Study:
- To investigate the effect of vasopressin on myocardial perfusion.
- To determine if vasopressin causes detectable changes in heart blood flow.
Main Methods:
- Thallium 201 (201Tl) myocardial scans were performed on 16 patients receiving vasopressin for gastrointestinal bleeding.
- Scans were repeated 2-3 hours after vasopressin infusion was discontinued.
Main Results:
- 69% of patients showed decreased myocardial 201Tl uptake during vasopressin infusion.
- These perfusion abnormalities resolved after vasopressin was stopped.
- Heart rate-blood pressure product was lower in repeat scans.
Conclusions:
- Low-dose vasopressin can induce myocardial perfusion abnormalities.
- These effects are likely due to a direct impact on coronary circulation.
- Vasopressin-induced cardiac changes may contribute to cardiovascular morbidity.